RECRUITING

A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is see if Cognitive Processing Therapy and STAIR Narrative Therapy work to treat posttraumatic stress disorder (PTSD) among lesbian, gay, bisexual, transgender, queer/questioning, intersex, asexual/aromantic, and all other sexual or gender minority (LGBTQIA+) adults. The main questions it aims to answer are: * Do these treatments reduce PTSD symptoms in LGBTQIA+ patients? * Do these treatments help improve quality of life and reduce depression in LGBTQIA+ patients? * Do stress from stigma and discrimination and drug/alcohol use change the impact of the treatment on PTSD symptoms? * Are LGBTQIA+ patients satisfied with these treatments? Do these treatments work differently among different groups within the LGBTQIA+ community? * Do LGBTQIA+ patients complete these treatments? Study participants will receive one of these two PTSD treatments. Participants will complete assessments before and after receiving treatment.

Official Title

LGBTQIA+ Initiative for Empowerment, Support, Coping, and PTSD Education: A Comparative Effectiveness Study of PTSD Treatments Among Sexual and Gender Minority Populations

Quick Facts

Study Start:2024-08-01
Study Completion:2028-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06367764

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 18 years of age or older
  2. 2. Currently live in California
  3. 3. Ability to understand study procedures and to comply with them for the entire length of the study
  4. 4. Ability to understand a written informed consent document and the willing to sign it
  5. 5. Ability to speak and read English or Spanish
  6. 6. Identify as a sexual and/or gender minority
  7. 7. Score 33 or higher on the PTSD Checklist-5 (PCL-5)
  8. 8. Interest in getting treatment for PTSD
  9. 9. Not be in another concurrent psychotherapy treatment (group or individual) for PTSD (psychotherapy treatment for non-PTSD conditions is allowed).
  1. 1. Contraindication to any study-related procedure or assessment
  2. 2. Clinically significant impairment which interferes with ability to fully participate in the study (including symptoms of schizophrenia, schizoaffective disorder, bipolar disorder, or other disorders)
  3. 3. Active suicidal intent

Contacts and Locations

Study Contact

Annesa P Flentje, PhD
CONTACT
415-502-4859
lgbtqia_study@ucsf.edu
Belin Marko, MA
CONTACT

Principal Investigator

Annesa P Flentje, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

UCSF Alliance Health Project
San Francisco, California, 94103
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Annesa P Flentje, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-08-01
Study Completion Date2028-06

Study Record Updates

Study Start Date2024-08-01
Study Completion Date2028-06

Terms related to this study

Keywords Provided by Researchers

  • PTSD
  • Therapy
  • LGBTQ
  • Depression
  • Comparative Effectiveness Trial
  • Substance Use
  • Minority Stress

Additional Relevant MeSH Terms

  • PTSD